The threat of tropical diseases is no longer confined to distant shores. A concerning trend is unfolding across Europe, with mosquito-borne illnesses like dengue fever, West Nile virus, and now chikungunya, gaining a foothold and demonstrating local transmission. Recent research indicates that the chikungunya virus, historically limited to tropical regions, is now capable of establishing itself across much of the continent due to rising temperatures, posing a significant public health challenge. This expansion isn’t merely a future possibility. local cases are already being reported with increasing frequency, demanding heightened vigilance and proactive preventative measures.
For decades, these diseases were primarily associated with travel to affected regions. However, milder winters and increasingly warmer summers are creating ideal breeding grounds for the Aedes albopictus (Asian tiger mosquito) and other tropical mosquito species within Europe itself. This shift means that individuals can now contract these illnesses without ever leaving the continent, fundamentally altering the risk landscape. The European Centre for Disease Prevention and Control (ECDC) has issued warnings about this growing threat, urging travelers to South and Eastern Europe to take precautions, but the reality is that the risk is expanding northward.
The situation in Belgium is particularly noteworthy. While previously, cases of these diseases were limited to travelers returning from endemic areas, recent reports confirm local transmission of chikungunya, meaning individuals have been infected by mosquitoes within the country. This marks a critical turning point, signaling that these diseases are becoming established within the European ecosystem. The implications are far-reaching, requiring a reassessment of public health strategies and a greater focus on mosquito control and disease surveillance.
Chikungunya: A Growing Concern Across Europe
Chikungunya virus, transmitted primarily by the Aedes albopictus mosquito, is characterized by debilitating joint pain that can persist for months, even years, after the initial infection. The name “chikungunya” itself originates from an African language and means “that which bends up,” describing the hunched posture often adopted by sufferers due to the severe joint pain. While typically not fatal, the chronic pain and fatigue associated with chikungunya can significantly impact quality of life. A study published in February 2026, highlighted by Business AM, demonstrates that climate warming is enabling the virus to spread to more northerly regions, with potential for sustained transmission for over six months annually in Southern European countries like Spain and Greece. Even the south of the United Kingdom is now experiencing conditions conducive to transmission for two months each year, and further northward expansion is anticipated.
The virus originated in Tanzania in 1952 and remained largely confined to tropical regions for many years. However, outbreaks in France and Italy in 2025, with hundreds of reported cases, signaled a dramatic shift. The Aedes albopictus mosquito, the primary vector for chikungunya, is now increasingly prevalent across Europe, facilitated by warmer temperatures and changing climate patterns. This mosquito is a daytime biter, increasing the risk of transmission during outdoor activities. The availability of vaccines for chikungunya is limited, and current options are often expensive and not widely accessible, further complicating the public health response.
The Rise of Mosquito-Borne Diseases in Europe: A Broader Trend
Chikungunya is not the only mosquito-borne disease on the rise in Europe. Dengue fever, also transmitted by the Aedes albopictus mosquito, has seen a significant increase in cases in recent years. According to VRT News, in 2023, 130 locally acquired dengue infections were reported across the European Union, a substantial increase compared to the 73 cases recorded between 2010 and 2021. This trend is expected to continue, with several European countries already reporting higher numbers of local infections this year than in the previous year. West Nile virus, spread by the Culex mosquito, is also expanding its reach, currently present in 123 regions across 9 EU countries, although case numbers were slightly lower in 2023 compared to 2022 (713 vs. 1,133 cases).
The increasing prevalence of these diseases is directly linked to the changing climate. Milder winters allow mosquito populations to survive and thrive, while warmer summers create more favorable breeding conditions. This allows tropical mosquito species to establish themselves in new areas, expanding the geographic range of these diseases. The fact that these infections are now occurring locally, rather than being imported by travelers, is a critical development, indicating that these diseases are becoming endemic to Europe.
Belgium’s Response and Public Health Measures
The confirmation of local chikungunya transmission in Belgium has prompted a response from public health authorities. While specific details of the Belgian response are still emerging, it is expected to include increased mosquito surveillance, public awareness campaigns, and measures to control mosquito populations. The Institute for Tropical Medicine (ITM) in Belgium plays a crucial role in monitoring and responding to tropical diseases, receiving approximately 24,000 travelers annually for pre- and post-travel health consultations. As of September 2025, the ITM reported a significant increase in dengue cases among returning travelers, with malaria remaining the most common diagnosis. The ITM emphasizes the importance of preventative measures, such as using mosquito repellent, wearing long sleeves and pants, and sleeping under mosquito nets, particularly in areas with known mosquito activity.
Currently, there is no local transmission of these viruses within Belgium, meaning all cases reported are linked to travel outside the country. However, the recent confirmation of local chikungunya transmission changes this dynamic. Public health officials are likely to focus on identifying and eliminating mosquito breeding sites, such as stagnant water in containers, tires, and gutters. They will also work to educate the public about the risks of mosquito-borne diseases and how to protect themselves.
Protecting Yourself from Mosquito-Borne Diseases
While the spread of these diseases is concerning, there are steps individuals can take to reduce their risk of infection. The most effective preventative measures include:
- Mosquito Repellent: Leverage insect repellents containing DEET, picaridin, or oil of lemon eucalyptus, following the manufacturer’s instructions carefully.
- Protective Clothing: Wear long sleeves, long pants, and socks when outdoors, especially during peak mosquito activity hours (dawn and dusk).
- Mosquito Nets: Sleep under mosquito nets, particularly in areas with high mosquito populations.
- Eliminate Breeding Sites: Remove standing water from around your home, including in containers, tires, and gutters.
- Window and Door Screens: Ensure that windows and doors have screens to prevent mosquitoes from entering your home.
Travelers to affected areas should consult with their healthcare provider about appropriate vaccinations and preventative medications. It’s also crucial to be aware of the symptoms of these diseases, which can include fever, headache, muscle and joint pain, rash, and fatigue. If you experience these symptoms after traveling to an area with mosquito-borne diseases, seek medical attention immediately.
The increasing prevalence of mosquito-borne diseases in Europe is a complex public health challenge that requires a coordinated response. Continued monitoring, research, and public health interventions are essential to mitigate the risk and protect the health of European citizens. The situation in Belgium serves as a stark reminder that these diseases are no longer a distant threat, but a growing reality that demands our attention.
Looking ahead, ongoing surveillance of mosquito populations and disease incidence will be crucial. Further research is needed to understand the factors driving the spread of these diseases and to develop more effective prevention and treatment strategies. The ECDC will continue to monitor the situation and provide guidance to member states. The next major update from the ECDC regarding mosquito-borne disease risk assessments is scheduled for June 2026. Stay informed and share this information with your community to aid raise awareness and promote preventative measures.